Thursday - October 23, 2025
UC-San Diego: Combination Therapy Could Expand Treatment Options for AML Patients, Extend Survival
October 21, 2025
LA JOLLA, California, Oct. 21 (TNSjou) -- The University of California San Diego campus issued the following news:

* * *

Combination Therapy Could Expand Treatment Options for AML Patients, Extend Survival

Proteasome inhibitors have proven highly effective in multiple myeloma but not in acute myeloid leukemia.

By Erin Prater - eprater@ucsd.edu

Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resis . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products